Qlgn earnings
WebApr 6, 2024 · Earnings are forecast to decline by an average of 11.6% per year for the next 3 years Does not have a meaningful market cap ($5M) Currently unprofitable and not forecast to become profitable over the next 3 years Shareholders have been diluted in the past year See all risk checks Snowflake Analysis My Notes WebApr 15, 2024 · The company has a market cap of $26.27 billion, a price-to-earnings ratio of 74.25, a price-to-earnings-growth ratio of 3.30 and a beta of 1.60. Align Technology, Inc. has a 12-month low of $172. ...
Qlgn earnings
Did you know?
WebQLGN Qualigen Therapeutics Inc 38,048 Watch $0.8722 $0.0308 (3.41%) Today $0.92 0.0436 (5.00%) After Hours Market Cap $3.67M Volume (M) 20,260.00 52-Wk High $15.20 … WebQualigen Therapeutics, Inc. Common Stock (QLGN) Nasdaq Listed OUT OF COMPLIANCE Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market …
WebApr 6, 2024 · View Qualigen Therapeutics, Inc QLGN investment & stock information. Get the latest Qualigen Therapeutics, Inc QLGN detailed stock quotes, stock data, Real-Time ECN, … WebApr 12, 2024 · In recent trading, shares of Align Technology Inc (Symbol: ALGN) have crossed above the average analyst 12-month target price of $330.67, changing hands for …
WebNov 22, 2024 · By David Bautz, PhD NASDAQ:QLGN READ THE FULL QLGN RESEARCH REPORT Financial Update On November 15, 2024, Qualigen Therapeutics, Inc. … WebMar 30, 2024 · QLGN Qualigen Therapeutics, Inc. Earnings Estimates 4.95K followers $0.92 0.02 ( +2.31%) 3:59 PM 03/30/23 NASDAQ $USD Post-Market: $0.95 +0.03 (+3.15%) 6:51 PM Summary Ratings Financials...
WebApr 4, 2024 · Detailed statistics for Qualigen Therapeutics, Inc. (QLGN) stock, including valuation metrics, financial numbers, share information and more. ... Estimated Earnings Date May 12, 2024: Ex-Dividend Date n/a: Share Statistics. QLGN has 4.21 million shares outstanding. The number of shares has increased by 35.89% in one year.
WebApr 11, 2024 · Align Technology (NASDAQ:ALGN - Get Rating) last announced its quarterly earnings data on Wednesday, February 1st. The medical equipment provider reported $1.28 EPS for the quarter, beating analysts' consensus estimates of $1.23 by $0.05. Align Technology had a return on equity of 11.90% and a net margin of 9.68%. eyes with tears clipartWebApr 3, 2024 · Get the latest QLGN: Qualigen Therapeutics detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.. ... a recap of their last earnings report; and a bulleted list of reasons to ... does bellco offer notary servicesWebP/E (TTM) -0.08 Fwd P/E (NTM) -0.63 EBITDA (TTM) -18.057M ROE (TTM) -145.43% Revenue (TTM) 5.075M Gross Margin (TTM) 12.77% Net Margin (TTM) -329.51% Debt To Equity … eyes with white backgroundWebMar 22, 2024 · QLGN Qualigen Therapeutics, Inc. Earnings Surprise 4.96K followers $1.00 -0.14 ( -12.28%) 3:59 PM 03/22/23 NASDAQ $USD Post-Market: $1.05 +0.05 (+5.00%) 7:15 PM Summary Ratings Financials... eyes with stars emojiWebApr 14, 2024 · NasdaqGS:ALGN Past Earnings Growth April 14th 2024. Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. does bell canada own rogersWebMar 30, 2024 · QLGN Qualigen Therapeutics, Inc. Earnings Estimates 4.95K followers $0.92 0.02 ( +2.31%) 3:59 PM 03/30/23 NASDAQ $USD Post-Market: $0.95 +0.03 (+3.15%) … eyes with white below the irisWebS100P Gene Expression May Be Marker of Anti-Tumor Activity in Pancreatic Cancer In Vivo Models CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential ... does bell end up with ryu